These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22821618)

  • 1. MEK1-induced physiological hypertrophy inhibits chronic post-myocardial infarction remodeling in mice.
    Yeh CC; Malhotra D; Yang YL; Xu Y; Fan Y; Li H; Mann MJ
    J Cell Biochem; 2013 Jan; 114(1):47-55. PubMed ID: 22821618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
    Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spacial and Temporal Patterns of Gene Expression After Cardiac MEK1 Gene Transfer Improve Post-Infarction Remodeling Without Inducing Global Hypertrophy.
    Fan Y; Yang YL; Yeh CC; Mann MJ
    J Cell Biochem; 2017 Apr; 118(4):775-784. PubMed ID: 27639174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
    Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin prevents cardiac cell apoptosis during cardiac remodelling post experimentally induced myocardial infarction in rats via activation of Raf-MEK1/2-ERK1/2 signalling.
    Eid RA; Alkhateeb MA; Al-Shraim M; Eleawa SM; Shatoor AS; El-Kott AF; Zaki MSA; Shatoor KA; Bin-Jaliah I; Al-Hashem FH
    Arch Physiol Biochem; 2019 May; 125(2):93-103. PubMed ID: 29447000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased C-reactive protein expression exacerbates left ventricular dysfunction and remodeling after myocardial infarction.
    Takahashi T; Anzai T; Kaneko H; Mano Y; Anzai A; Nagai T; Kohno T; Maekawa Y; Yoshikawa T; Fukuda K; Ogawa S
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1795-804. PubMed ID: 20852043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.
    Krishnamurthy P; Rajasingh J; Lambers E; Qin G; Losordo DW; Kishore R
    Circ Res; 2009 Jan; 104(2):e9-18. PubMed ID: 19096025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion.
    Rajani SF; Imani A; Faghihi M; Izad M; Kardar GA; Salehi Z
    Eur J Pharmacol; 2019 Mar; 847():61-71. PubMed ID: 30684466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
    Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
    JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
    Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
    J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.
    Gravning J; Ørn S; Kaasbøll OJ; Martinov VN; Manhenke C; Dickstein K; Edvardsen T; Attramadal H; Ahmed MS
    PLoS One; 2012; 7(12):e52120. PubMed ID: 23284892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Parkin protein in cardiac function and ventricular remodeling in myocardial infarction rats.
    Zhang SX; Zhuang LL; Liu J; Jing YY; Sun J; Gong L; Liu XY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):5004-5013. PubMed ID: 30070337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.
    Lauer D; Slavic S; Sommerfeld M; Thöne-Reineke C; Sharkovska Y; Hallberg A; Dahlöf B; Kintscher U; Unger T; Steckelings UM; Kaschina E
    Hypertension; 2014 Mar; 63(3):e60-7. PubMed ID: 24379181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice.
    Zavadzkas JA; Stroud RE; Bouges S; Mukherjee R; Jones JR; Patel RK; McDermott PJ; Spinale FG
    Circ Res; 2014 Apr; 114(9):1435-45. PubMed ID: 24637197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction.
    Oba T; Yasukawa H; Hoshijima M; Sasaki K; Futamata N; Fukui D; Mawatari K; Nagata T; Kyogoku S; Ohshima H; Minami T; Nakamura K; Kang D; Yajima T; Knowlton KU; Imaizumi T
    J Am Coll Cardiol; 2012 Feb; 59(9):838-52. PubMed ID: 22361405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.